Investigators will present detailed findings from a phase 2 study assessing a tambiciclib-based regimen in patients with relapsed/refractory AML at ASH 2026.
News|Articles|July 23, 2009
Oncology NEWS International
- Oncology NEWS International Vol 18 No 7
- Volume 18
- Issue 7
Bristol-Myers Squibb launches leukemia website
Patients with chronic myeloid leukemia can learn more about the disease at a new educational Web portal.
Advertisement
Patients with chronic myeloid leukemia can learn more about the disease at a new educational Web portal.
MyCMLCare.com offers downloadable information on CML symptoms, recommended treatment goals, tests, and side effects as well as other resources for disease management.
Articles in this issue
over 17 years ago
Less is more when it comes to serial CA125 testing in ovarian cancerover 17 years ago
Treatment varies widely in chronic myeloid leukemiaover 17 years ago
Oncology takes blame for rising healthcare costover 17 years ago
NSABP chair admits ‘failure’ in C-08 trial, denies defeatAdvertisement
Related to this article
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves OncoMate MSI Dx as Pembrolizumab Companion Diagnostic in MSI-H Solid Tumors
2
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumors
3
Hyperthermic Mitomycin C Yields 68% 1-Year HG-RFS in BCG-Unresponsive NMIBC
4
Acylfulvene Prodrug LP-184 Shows Tolerability in Recurrent Glioblastoma
5